China Enhances Supervision Of Narcotic APIs With Tighter Supply Chain Controls
This article was originally published in PharmAsia News
Executive Summary
SHANGHAI - China's State FDA recently asked local FDAs to implement a new provision for drug precursor chemicals that will strengthen the supervision of narcotics to address the increasing problem of drug abuse across the country